Results 261 to 265 of about 271,705 (265)

Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

Lancet Oncology, The
Ernest Nadal, Amelia Insa, Alex Martinez-Marti   +2 more
exaly  

Frailty and perioperative outcomes

openaire   +1 more source

Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer

Nature Reviews Clinical Oncology
exaly  

Adding durvalumab to perioperative FLOT improves gastric cancer outcomes

Nature Reviews Clinical Oncology
exaly  

Perioperative Pain Management & Enhanced Outcomes

2013
Carli F, BALDINI G
openaire   +1 more source